Vifor Pharma Inc.
- Address
- 1000 1st Avenue Suite 300
Sponsor Overview
Specializations
Hyperkalemia and Potassium Regulation
Vifor Pharma Inc. focuses on clinical research in hyperkalemia, with particular attention to the management of elevated blood potassium levels in pediatric populations. The sponsor’s funded trial activity centers on treatment approaches for children under 12 years of age affected by abnormal potassium balance.
- Hyperkalemia
- Pediatric electrolyte disorders
- Potassium-lowering therapy
Its current research interest is concentrated on care for young patients requiring control of clinically significant serum potassium elevation.
Pediatric Nephrology
The sponsor’s trial portfolio includes pediatric studies relevant to nephrology, especially conditions linked to impaired potassium handling and renal-related electrolyte disturbance. This area reflects interest in treatment options for children with kidney-related metabolic imbalance.
- Pediatric nephrology
- Electrolyte imbalance
- Renal potassium homeostasis
Research activity in this domain supports therapeutic development for managing potassium excess in younger patients with complex medical needs.
Children's Internal Medicine
Vifor Pharma Inc. is engaged in research addressing pediatric internal medicine concerns where abnormal potassium levels require targeted treatment. The funded study examines clinical use in children aged 0 to under 12 years, highlighting a focus on age-specific medical management.
- Pediatric medicine
- Electrolyte management
- Child health
This therapeutic area is centered on supporting clinical care for children with high blood potassium levels.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Pharmacodynamic Effects, Safety, and Tolerability of Patiromer in Pediatric Patients with Hyperkalemia: A Phase 2, Open-Label, Multiple Dose Study |  Belgium Finland France Greece Hungary Italy Norway Poland Portugal Romania Slovakia | Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.
This sponsor has worked with 16 sites across their trial portfolio.
Therapeutic Focus
- 1.Nutritional and Metabolic Diseases1 trial211 other sponsors
Partnered Research Centres
16 centres- Address
- Thivon And Leivadias, Ampelokipoi, 115 27 Athens
- Address
- 80 Avenue Augustin Fliche, 34295 Montpellier
- Address
- 1 Place Du Docteur Joseph Baylac, 31300 Toulouse
- Address
- Largo Professor Abel Salazar, 4050-011 Porto
- Address
- Via Francesco Sforza 28, 20122 Milan
- Address
- Haukelandsveien 22, 5021 Bergen
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Vifor Pharma Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.